Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results.

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results.

BACKGROUND: Few studies have formally assessed whether treatment outcomes have improved substantially over the years for patients with extensive disease small-cell lung cancer (ED-SCLC) enrolled in phase III trials. The objective of the current investigation was to determine the time trends in outco...

Full description

Bibliographic Details
Main Authors: Isao Oze, Katsuyuki Hotta, Katsuyuki Kiura, Nobuaki Ochi, Nagio Takigawa, Yoshiro Fujiwara, Masahiro Tabata, Mitsune Tanimoto
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2773043?pdf=render

Internet

http://europepmc.org/articles/PMC2773043?pdf=render

Similar Items